Publication Year

Enright BP, Compton DR, Collins N, Davis T, McIntyre BS. 2009. Comparative effects of interferon alpha-2b and pegylated interferon alpha-2b on menstrual cycles and ovarian hormones in Cynomolgus monkeys. Birth Defects Res B 86(1):29–39; doi: 10.1002/bdrb.20179. PMID: 19243028.

Wheeler MW, Bailer AJ. 2009. Benchmark dose estimation incorporating multiple data sources. Risk Anal 29(2):249-56; doi: 10.1111/j.1539-6924.2008.01144x. PMID: 19000080.

Thompson CM, Johns DO, Sonawane S, Barton HA, Hattis D, Tardif R, Krishnan K. 2009. Database for physiologically based pharmacokinetic (PBPK) modeling: Physiological parameters for healthy and health-impaired elderly. J Toxicol Environ Health B 12(1):1–24; doi: 10.1080/10937400802545060. PMID: 19117207.

Clewell RA, Kremer JJ, Williams CC, Campbell JL, Sochaski MA, Andersen ME, Borghoff SJ. 2009. Kinetics of selected di-n-butyl phthalate metabolites and fetal testosterone following repeated and single administration in pregnant rats. Toxicology 255(1–2):80–90; doi: 10.1016/j.tox.2008.10.010. PMID: 19010379.

Mink PJ, Alexander DD, Barraj LM, Kelsh MA, Tsuji JS. 2008. Low-level arsenic exposure in drinking water and bladder cancer: A review and meta-analysis. Regul Toxicol Pharmacol 52(3):299–310.